JNJ

227.15

-0.05%↓

ABT

91.94

-1.63%↓

MDT

79.22

-2.69%↓

A

110.72

-3.72%↓

VEEV

157.58

-0.51%↓

JNJ

227.15

-0.05%↓

ABT

91.94

-1.63%↓

MDT

79.22

-2.69%↓

A

110.72

-3.72%↓

VEEV

157.58

-0.51%↓

JNJ

227.15

-0.05%↓

ABT

91.94

-1.63%↓

MDT

79.22

-2.69%↓

A

110.72

-3.72%↓

VEEV

157.58

-0.51%↓

JNJ

227.15

-0.05%↓

ABT

91.94

-1.63%↓

MDT

79.22

-2.69%↓

A

110.72

-3.72%↓

VEEV

157.58

-0.51%↓

JNJ

227.15

-0.05%↓

ABT

91.94

-1.63%↓

MDT

79.22

-2.69%↓

A

110.72

-3.72%↓

VEEV

157.58

-0.51%↓

Search

Quidel Corp

Ouvert

11.24 -5.78

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.21

Max

12.07

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+68.19% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-498M

712M

Ouverture précédente

17.02

Clôture précédente

11.24

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 avr. 2026, 23:33 UTC

Actions en Tendance

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

28 avr. 2026, 23:24 UTC

Résultats

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

28 avr. 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

28 avr. 2026, 22:46 UTC

Résultats

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

28 avr. 2026, 22:37 UTC

Résultats

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

28 avr. 2026, 22:15 UTC

Résultats
Principaux Événements d'Actualité

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

28 avr. 2026, 23:33 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

28 avr. 2026, 23:31 UTC

Résultats

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

28 avr. 2026, 23:31 UTC

Résultats

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

28 avr. 2026, 23:30 UTC

Résultats

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

28 avr. 2026, 23:30 UTC

Résultats

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

28 avr. 2026, 23:19 UTC

Market Talk
Résultats

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

28 avr. 2026, 23:09 UTC

Résultats

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

28 avr. 2026, 23:03 UTC

Market Talk

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR Sees One Rate Rise to 4% in Benign Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

28 avr. 2026, 23:01 UTC

Principaux Événements d'Actualité

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

28 avr. 2026, 22:51 UTC

Résultats

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

28 avr. 2026, 22:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28 avr. 2026, 22:48 UTC

Market Talk

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

28 avr. 2026, 22:40 UTC

Market Talk
Principaux Événements d'Actualité

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

28 avr. 2026, 22:32 UTC

Résultats

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

28 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

Pernod Ricard and Brown-Forman End Deal Talks -- Update

28 avr. 2026, 22:22 UTC

Résultats

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

28 avr. 2026, 22:17 UTC

Market Talk

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

28 avr. 2026, 22:14 UTC

Résultats

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

28 avr. 2026, 22:14 UTC

Résultats

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

28 avr. 2026, 22:07 UTC

Market Talk
Principaux Événements d'Actualité

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

68.19% hausse

Prévisions sur 12 Mois

Moyen 20.67 USD  68.19%

Haut 30 USD

Bas 15 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat